Search - tctmd.com

Displaying 21 - 40 of 239

Sort: Relevancy | Date

News Daily News

Going Contrast Free in TAVI Is Safe for CKD Patients

Caitlin E. Cox

August 20, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Shelley Wood

July 09, 2024

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

Presentation NY Valves 2024

Procedural Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement Planning With Contrast-Enhanced Computed Tomography Versus Non-Contrast Computed Tomography and Cardiac Magnetic Resonance

Presenter: Besir Besir

June 07, 2024

News Conference News NY Valves 2024

Long-term Mortality After TAVI Lower With DOACs vs VKAs

Todd Neale

June 06, 2024

Presentation NY Valves 2024

Demonstration of the Mitraclip and the PASCAL Device: Compare and Contrast with Discussion

Presenter: Guido Ascione

June 06, 2024

Presentation NY Valves 2024

Contrast-Sparing IVUS-Guided Bicaval Valve Implantation for Severe Tricuspid Regurgitation

Presenter: Nikolaos Spilias

June 05, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

News Conference News ACC 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

L.A. McKeown

April 07, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

Yael L. Maxwell

January 22, 2024

News Conference News PCR London Valves 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

TCT 301: Quantifying Calcific Progression Using Contrast-Enhanced CT: Severity, and Sex Variations in AS

Presenter: Zahra K. Motamed

October 25, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Advertisement

Going Contrast Free in TAVI Is Safe for CKD Patients

August 2024 Dispatch for the CV Team

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Procedural Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement Planning With Contrast-Enhanced Computed Tomography Versus Non-Contrast Computed Tomography and Cardiac Magnetic Resonance

Long-term Mortality After TAVI Lower With DOACs vs VKAs

Demonstration of the Mitraclip and the PASCAL Device: Compare and Contrast with Discussion

Contrast-Sparing IVUS-Guided Bicaval Valve Implantation for Severe Tricuspid Regurgitation

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

FDA Approves TriClip TEER Device for Tricuspid Repair

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

TCT 301: Quantifying Calcific Progression Using Contrast-Enhanced CT: Severity, and Sex Variations in AS

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content